| Literature DB >> 33176872 |
El Hadji Diouf1, El Hadji Amadou Niang2, Badara Samb2, Cheikh Tidiane Diagne3, Mbaye Diouf2, Abdoulaye Konaté2, Ibrahima Dia3, Ousmane Faye2, Lassana Konaté2.
Abstract
BACKGROUND: High coverage of long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) are the cornerstones of vector control strategy in Senegal where insecticide resistance by the target vectors species is a great of concern. This study explores insecticide susceptibility profile and target-site mutations mechanisms within the Anopheles gambiae complex in southeastern Senegal.Entities:
Keywords: A296G; A296S; Ace-1; An.arabiensis; An.coluzzii; An.gambiae (s.s.); Insecticide resistance; Senegal; Vgsc-1014F; Vgsc-1014S
Mesh:
Substances:
Year: 2020 PMID: 33176872 PMCID: PMC7661151 DOI: 10.1186/s13071-020-04437-z
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Fig. 1Map showing mosquito sampling areas in southeastern Senegal
Fig. 2Mortality rates of Anopheles gambiae (s.l.) 24 h populations after exposure to WHO recommended insecticide doses in October and November 2014
Mortality rates following insecticides (pyrethroids, DDT and dieldrin) exposure of Anopheles gambiae (s.l.) populations from Kedougou and Wassadou-Badi in October and November 2014
| Locality | Insecticide | Mortality rate (%) ( | KDT50 (min) | KDT95 (min) |
|---|---|---|---|---|
| Kedougou | DDT | 12.8 (211) | 161 (119.3–267.1) | 784.95 (420.5–2287.9) |
| Permethrin | 53.2 (220) | 164.89 (122.6–263.2) | 1234.25 (634–3563.8) | |
| Deltamethrin | 67.9 (240) | 161 (128–222.8) | 784.95 (490.7–1556.5) | |
| Lambda-cyhalothrin | 57.1 (231) | 53.92 (49.2–60.5) | 149.27 (118.7–208.3) | |
| Cyfluthrin | 81.4 (200) | 22.72 (20.7–24.8) | 65.63 (56.4–80.2) | |
| Alpha-cypermethrin | 42.8 (217) | 28.35 (26.8–30) | 84 (74.9–96.6) | |
| dieldrin | 67.8 (239) | 97.56 (73.3–324.7) | 223.3 (123.2–3120.3) | |
| Wassadou-Badi | DDT | 55.8 (116) | 161 (119.3–267.1) | 784.95 (420–2287.9) |
| Permethrin | 58 (119) | 47.47 (43.4–52.9) | 153.23 (121.9–210) | |
| Deltamethrin | 68 (122) | 58.8 (50.0–68.0) | 113.38 (97.73–139.3) | |
| Lambda-cyhalothrin | 53.4 (118) | 63.56 (56.5–75.5) | 174.65 (130.3–280.7) | |
| Cyfluthrin | 86.4 (109) | 41.7 (49.8–105.6) | 87.45 (87.5–139.6) | |
| Alpha-cypermethrin | 86 (110) | 27.63 (25.6–29.7) | 62.94 (55.8–73.6) | |
| dieldrin | 83 (124) | 0 (–) | 0 (–) |
Abbreviations: n, number of mosquitoes tested; 95% CI, 95% confidence interval; KDT50 and KDT95, knock down 50% and 95%; min, minutes
Genotypes and allelic frequencies of mutations Vgsc-1014F, Vgsc-1014S, Ace-1 (G119S), rdl-A296S, and rdl-A296G in An. arabiensis, An. coluzzii and An. gambiae (s.s.) in Kedougou and Wassadou-Badi in October and November 2014
| Localities | Species | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LL | LF | FF | (freq R) | LL | LS | SS | (freq R) | ||||
| Kedougou | 23 | 1 | 3 | 0.129 | ˂ 0.001 | 14 | 0 | 0 | 0.00 | na | |
| 0 | 1 | 18 | 0.973 | 0 | 0 | 0 | 0.00 | ||||
| 0 | 1 | 298 | 0.998 | 2 | 0 | 0 | 0.00 | ||||
| Wassadou-Badi | 114 | 3 | 3 | 0.037 | < 0.001 | 55 | 11 | 12 | 0.22 | < 0.001 | |
| 10 | 5 | 10 | 0.500 | 8 | 0 | 0 | 0.00 | ||||
| 3 | 0 | 134 | 0.978 | 0 | 0 | 10 | 1 | ||||
Abbreviations: P, probability of significant difference for each mutation among species within each site; L, leucine; F, phenylalanine; S, serine; G, glycine; A, alanine; Freq R, frequency of resistant allele; na, not applicable, FF, phenyl alanine- phenyl alanine
Numbers of specimens and frequencies of G119S and rdl A296G or rdl A296S mutations by surviving or dead phenotypes in An. arabiensis, An.coluzzii and An. gambiae (s.s.) of Kedougou and Wassadou-Badi in October and November 2014
| Locality | Phenotype | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Kedougou | ||||||||||
| | Surviving | 11 | 0.31 | 0.031 | 18 | 0.97 | 248 | 1.0 | ||
| Dead | 16 | 0.06 | 0 | 0.0 | na | 15 | 0.97 | 0.057 | ||
| | Surviving | 2 | 0.00 | na | 1 | 0.00 | 42 | 0.00 | ||
| Dead | 12 | 0.00 | 0 | 0.00 | 16 | 0.00 | na | |||
| Wassadou-Badi | ||||||||||
| | Surviving | 51 | 0.068 | 0.017 | 11 | 0.6 | 0.44 | 100 | 0.98 | |
| Dead | 41 | 0 | 8 | 0.37 | 9 | 0.88 | 0.07 | |||
| | Surviving | 24 | 0.48 | 3 | 0.00 | 51 | 1.0 | |||
| Dead | 33 | 0.07 | < 0.001 | 7 | 0.00 | na | 6 | 0.00 | na | |
| Kedougou | ||||||||||
| | Surviving | 21 | 0.00 | na | 0 | 0.00 | 31 | 0.47 | ||
| Dead | 33 | 0.00 | 2 | 0.00 | na | 22 | 0.11 | < 0.001 | ||
| | Surviving | 2 | 0.00 | na | 2 | 0.00 | 34 | 0.21 | ||
| Dead | 0 | 0.00 | 0 | 0.00 | na | 15 | 0.00 | 0.004 | ||
| Wassadou-Badi | ||||||||||
| | Surviving | 0 | 0.00 | na | 1 | 0.00 | na | 11 | 0.36 | 0.034 |
| Dead | 11 | 0.00 | 1 | 0.00 | 6 | 0.00 | ||||
| | Surviving | 2 | 0.00 | na | – | – | – | – | – | – |
| Dead | 6 | 0.00 | – | – | – | – | – | – | ||
Abbreviations: freq R, allelic frequency of mutation studied; n, number of treated specimens; na, not applicable